Graham Capital Management’s Intellia Therapeutics NTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.2M Buy
+234,764
New +$2.2M 0.03% 302
2024
Q3
Sell
-10,818
Closed -$242K 1229
2024
Q2
$242K Buy
+10,818
New +$242K 0.01% 770
2022
Q4
Sell
-17,892
Closed -$1M 1235
2022
Q3
$1M Buy
+17,892
New +$1M 0.04% 481